UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 228

Sortiert nach

Translation control of the immune checkpoint in cancer and its therapeutic targeting

Nature medicine, 2019-02, Vol.25 (2), p.301-311

2019

Volltextzugriff (PDF)

RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions

Nature immunology, 2019-12, Vol.20 (12), p.1610

2019

Volltextzugriff (PDF)

The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes

Science signaling, 2016-05, Vol.9 (430), p.ra57

2016

Volltextzugriff (PDF)

Germline SAMD9L truncation variants trigger global translational repression

The Journal of experimental medicine, 2021-05, Vol.218 (5)

2021

Volltextzugriff (PDF)

mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition

Proceedings of the National Academy of Sciences - PNAS, 2014-11, Vol.111 (47), p.E5076-E5085

2014

Volltextzugriff (PDF)

Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1

PloS one, 2014-02, Vol.9 (2), p.e88865-e88865

2014

Volltextzugriff (PDF)

Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell function

PloS one, 2014-06, Vol.9 (6), p.e99486-e99486

2014

Volltextzugriff (PDF)

Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons

Immunity (Cambridge, Mass.), 2019-09, Vol.51 (3), p.451-464.e6

2019

Volltextzugriff (PDF)

PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances

Biochemical journal, 2012-03, Vol.442 (3), p.465-481

2012

Volltextzugriff (PDF)

Re-evaluating Strategies to Define the Immunoregulatory Roles of miRNAs

Trends in immunology, 2017-08, Vol.38 (8), p.558-566

2017

Volltextzugriff (PDF)

A Novel Role for the 4E-BP/eIF4E Axis in B Cell Antibody Class Switching

The Journal of immunology (1950), 2016-05, Vol.196 (1_Supplement), p.56-56.4

2016

Volltextzugriff (PDF)

Regulatory T cells suppress CD4+ effector T cell activation by controlling protein synthesis

The Journal of experimental medicine, 2023-03, Vol.220 (3)

2023

Volltextzugriff (PDF)

The canonical antiviral protein oligoadenylate synthetase 1 elicits antibacterial functions by enhancing IRF1 translation

Immunity (Cambridge, Mass.), 2024-08, Vol.57 (8), p.1812-1827.e7

2024

Volltextzugriff (PDF)

Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon production

Immunity (Cambridge, Mass.), 2024-03, Vol.57 (3), p.446-461.e7

2024

Volltextzugriff (PDF)

Quantitative proteomic and genetic analyses of the schizophrenia susceptibility factor dysbindin identify novel roles of the biogenesis of lysosome-related organelles complex 1

The Journal of neuroscience, 2012-03, Vol.32 (11), p.3697-3711

2012

Volltextzugriff (PDF)

Oligoadenylate Synthetase 1 enhances DNA sensor cGAS translation to mediate WNV antiviral activity

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.249-249.15

2020

Volltextzugriff (PDF)

Reciprocal effects of rab7 deletion in activated and neglected T cells

Autophagy, 2013-07, Vol.9 (7), p.1009-1023

2013

Volltextzugriff (PDF)

Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function

The Journal of biological chemistry, 2013-02, Vol.288 (8), p.5718-5731

2013

Volltextzugriff (PDF)

Abstract IA16: Mechanisms of resistance to mTOR inhibitors in leukemia and lymphoma

Molecular cancer therapeutics, 2015-07, Vol.14 (7_Supplement), p.IA16-IA16

2015

Volltextzugriff (PDF)

mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition

Proceedings of the National Academy of Sciences - PNAS, 2014-11, Vol.111 (47), p.16646-16646

2014

Volltextzugriff (PDF)

Effects of novel TOR inhibitors on B cell differentiation (159.5)

The Journal of immunology (1950), 2011-04, Vol.186 (1_Supplement), p.159-159.5

2011

Volltextzugriff (PDF)

The PI3K-mTOR Pathway in Mammals: From Therapeutics to Fundamentals

So, Lomon

2015

Volltextzugriff (PDF)

Abstract 1798: TORC1/2 inhibitors have more potent anti-leukemic efficacy and are less immunosuppressive than rapamycin

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1798-1798

2010

Volltextzugriff (PDF)

Resistance to mTOR Kinase Inhibitors in Lymphoma Cells Lacking 4EBP1: e88865

PloS one, 2014-02, Vol.9 (2)

2014

Volltextzugriff (PDF)

1 – 25 von 228

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(137)
Mit Volltextzugriff
(206)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Physics
(57)
Physical Sciences
(54)
Life Sciences & Biomedicine
(34)
Humans
(29)
Interactions
(23)
Physics, Multidisciplinary
(22)
Male
(18)
Scattering
(18)
Female
(17)
Middle Aged
(16)
Physics, Nuclear
(15)
Particle Models
(14)
Physics, Particles & Fields
(14)
Astronomy & Astrophysics
(13)
Animals
(12)
Boundary Conditions
(12)
Elementary Particles
(12)
Physics Of Elementary Particles And Fields
(12)
Aged
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Translation control of the immune checkpoint in cancer and its therapeutic targeting

RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions

The 4E-BP-eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes

Germline SAMD9L truncation variants trigger global translational repression

mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition

Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1

Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell function

Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons

PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances

Re-evaluating Strategies to Define the Immunoregulatory Roles of miRNAs

A Novel Role for the 4E-BP/eIF4E Axis in B Cell Antibody Class Switching

Regulatory T cells suppress CD4+ effector T cell activation by controlling protein synthesis

The canonical antiviral protein oligoadenylate synthetase 1 elicits antibacterial functions by enhancing IRF1 translation

Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon production

Quantitative proteomic and genetic analyses of the schizophrenia susceptibility factor dysbindin identify novel roles of the biogenesis of lysosome-related organelles complex 1

Oligoadenylate Synthetase 1 enhances DNA sensor cGAS translation to mediate WNV antiviral activity

Reciprocal effects of rab7 deletion in activated and neglected T cells

Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function

Abstract IA16: Mechanisms of resistance to mTOR inhibitors in leukemia and lymphoma

mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition

Effects of novel TOR inhibitors on B cell differentiation (159.5)

The PI3K-mTOR Pathway in Mammals: From Therapeutics to Fundamentals

Abstract 1798: TORC1/2 inhibitors have more potent anti-leukemic efficacy and are less immunosuppressive than rapamycin

Resistance to mTOR Kinase Inhibitors in Lymphoma Cells Lacking 4EBP1: e88865

Suchergebnisse filtern